Optimization of Gene Delivery Mediated by Lipoplexes and Electroporation into Mouse Mesenchymal Stem Cells

  • Kim, Jong-Chul (Department of Biomedical Laboratory Science, Yonsei University) ;
  • Kim, Hong-Sung (Department of Biomedical Laboratory Science, Korea Nazarene University) ;
  • Lee, Yeon-Kyung (Department of Biomedical Laboratory Science, Yonsei University) ;
  • Kim, Jung-Seok (Department of Biomedical Laboratory Science, Yonsei University) ;
  • Park, Sang-Il (Department of Biomedical Laboratory Science, Yonsei University) ;
  • Jung, Hwa-Yeon (Department of Biomedical Laboratory Science, Yonsei University) ;
  • Park, Yong-Serk (Department of Biomedical Laboratory Science, Yonsei University)
  • Published : 2009.12.31

Abstract

Recently, mesenchymal stem cells (MSCs) began to be utilized as a vehicle for ex vivo gene therapy based on their plasticity. Effective and safe transfection of therapeutic genes is a critical step for genetic modification of MSCs. Therefore, optimization of in vitro gene delivery into MSCs is essential to provide genetically modified stem cells. In this study, various cationic liposomes, O,O'-dimyristyl-N-lysyl aspartate (DMKD), DMKD/cholesterol, O,O'-dimyristyl-N-lysyl glutamate (DMKE), DMKE/cholesterol, and N-[1-(2,3-dioleoyloxy)]-N,N,N-trimethylammonium propane methyl sulfate (DOTAP)/cholesterol, were mixed with plasmid DNA encoding luciferase (pAAV-CMV-Luc) at varied ratios, and then used for transfection to MSCs under varied conditions. The MSCs were also transfected by electroporation under varied conditions, such as voltage, pulse length, and pulse interval. According to the experimental results, electroporation-mediated transfection was more efficient than cationic liposome-mediated transfection. The best MSC transfection was induced by electroporation 3 times pulses for 2 ms at 200 V with 10 seconds of a pulse interval.

Keywords

References

  1. Carmichael J, deGraff WG, Gazdar AF, Minna JD, Mitchel JB. Evaluation of a tetrazoliumbased semiautomated colorimetric assay: assessment of radio sensitivity. Cancer Res. 1987. 47: 936-942.
  2. Chaudhary LR, Hofmeister AM, Hruska KA. Diffenential growth factor control of bone formation through osteoprogenitor differentiation. Bone 2004. 34: 402-411. https://doi.org/10.1016/j.bone.2003.11.014
  3. Conrad C, Gupta R, Mohan H, Niess H, Bruns CJ, Kopp R, Luettichau IV, Guba M, Heeschen C, Jauch KW, Huss R, Nelson PJ. Genetically Engineered Stem Cells for Therapeutic Gene Delivery. Curr Gene Ther. 2007. 7: 249-260. https://doi.org/10.2174/156652307781369119
  4. Corsi K, Chellat F, Yahia L, Fernandes JC. Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials 2003. 24: 1255-1264. https://doi.org/10.1016/S0142-9612(02)00507-0
  5. Dennis JE, Caplan AI. Differentiation potential of conditionally immortalized mesenchymal progenitor cells from adult marrow of an H-2Kb-tsA58 transgenic mice. J Cell Physiol. 1996. 167: 523-538. https://doi.org/10.1002/(SICI)1097-4652(199606)167:3<523::AID-JCP16>3.0.CO;2-4
  6. Dennis JE, Merriam A, Awadallah A. Yoo JU, Johnstone B, Caplan AI. A quadripotential mesnechymal progenitor cell isolated from the marrow of an adult mouse. J Bone Miner Res. 1999. 14: 700-709. https://doi.org/10.1359/jbmr.1999.14.5.700
  7. Dezawa M, Kanno H, Hoshino M, Cho H, Matsumoto N, Itokazu Y, Tajima N, Yamada H, Sawada H, Ishikawa H, Mimura T, Kitada M, Suzuki Y, Ide C. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest. 2004. 113: 1701-1710. https://doi.org/10.1172/JCI200420935
  8. Ebisawa K, Hata KI, Okada K, Kimata K, Ueda M, Torii S, Watanabe H. Ultrasound Enhances Transforming Growth Factor ${\beta}-Mediated$ Chondrocyte Differentiation of Human Mesenchymal Stem Cells. Tissue Engineering 2004. 10: 921-929. https://doi.org/10.1089/1076327041348437
  9. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. Osteogenic differentiation of purified, culture-expanded human mesenchyman stem cells in vitro. J Cell Biochem. 1997. 64: 295-312. https://doi.org/10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
  10. Kassem M. Mesenchymal stem cells: Biological characteristics and potential clinical applications. Cloning Stem cells 2004. 6: 369-374. https://doi.org/10.1089/clo.2004.6.369
  11. Kim HS, Moon J, Kim KS, Choi MM, Lee JE, Heo Y, Cho DH, Jang DO, Park YS. Gene Transferring Efficiencies of Novel Diamino Cationic Lipids with Varied Hydrocarbon Chains. Bioconjugate Chem. 2004. 15: 1095-1101. https://doi.org/10.1021/bc049934t
  12. Kim HS, Song IH, Kim JC, Kim EJ, Jang DO, Park YS. In vitro and in vivo gene-transferring characteristics of novel cationic lipids, DMKD (O,O'-dimyristyl-N-lysyl aspartate) and DMKE (O,O'-dimyristyl-N-lysyl glutamate). J Control Rel. 2006. 115: 234-241. https://doi.org/10.1016/j.jconrel.2006.08.003
  13. Lee K, Kuo TK, Whang-Peng J, Chung YF, Lin CT, Chou SH, Chen JR, Chen YP, Lee OK. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 2004. 40: 1275-1284. https://doi.org/10.1002/hep.20469
  14. Miyahara Y, Nagaya N, Kataoka M, Yanagawa B, Tanaka K, Hao H, Ishino K, Ishida K, Shimizu T, Kangawa K, Sano S, Okano T, Kitamura S, Mori H. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med. 2006. 12: 459-465. https://doi.org/10.1038/nm1391
  15. Peister A, Mellad JA, Wang M, Tucker HA, Prockop DJ. Stable transfection of MSCs by electroporation. Gene Ther. 2004. 11: 224-228. https://doi.org/10.1038/sj.gt.3302163
  16. Reiser J, Zhang XY, Hemenway CS, Mondal D, Pradhan L, Russa VFL. Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases. Expert Opin Biol Ther. 2005. 5: 1571-1584. https://doi.org/10.1517/14712598.5.12.1571
  17. Ren C, Kumar S, Chanda D, Chen J, Mountz JD, Ponnazhagan S. Therapeutic Potential of Mesenchymal Stem Cells Producing $Interferon-{\alpha}$ in a Mouse Melanoma Lung Metastasis Model. Stem Cells 2008. 26: 2332-2338. https://doi.org/10.1634/stemcells.2008-0084
  18. Secchiero P, Melloni E, Corallini F, Beltrami AP, Alviano F, Milani D, D'Aurizio F, Iasio MG, Cesselli D, Bagnara GP, Zauli G. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Promotes Migration of Human Bone Marrow Multipotent Stromal Cells. Stem Cells 2008. 26: 2955-2963. https://doi.org/10.1634/stemcells.2008-0512
  19. Tian Jand, Andreadis ST. Independent and high-level dual-gene expression in adult stem-progenitor cells from a single lentiviral vector. Gene Ther. 2009. 16: 874-884. https://doi.org/10.1038/gt.2009.46
  20. Yang J, Zhou W, Zheng W, Ma Y, Lin L, Tang T, Liu J, Yu J, Zhou X, Hu J. Effects of Myocardial Transplantation of Marrow Mesenchymal Stem Cells Transfected with Vascular Endothelial Growth Factor for the Improvement of Heart Function and Angiogenesis after Myocardial Infarction. Cardiology 2007. 107: 17-29. https://doi.org/10.1159/000093609